- Presentations
- 3
- Markets
- 1
Glassia is a brand of .alpha.1-proteinase inhibitor human marketed by Takeda Pharmaceuticals, with 3 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- .alpha.1-proteinase inhibitor human
- Brand owner
- Takeda Pharmaceuticals
- Registered in
- United States
- Strengths and forms
- 1 g/50 mL injection, 4 g/200 mL injection, 5 g/250 mL injection
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Glassia 1 g/50 mL injectionIntravenous Cold chain | Takeda Pharmaceuticals | US FDA | Available on request |
| Glassia 4 g/200 mL injectionIntravenous Cold chain | Takeda Pharmaceuticals | US FDA | Available on request |
| Glassia 5 g/250 mL injectionIntravenous Cold chain | Takeda Pharmaceuticals | US FDA | Available on request |
Equivalent brands
Other brands of .alpha.1-proteinase inhibitor human.
Brand names and trademarks belong to their owners and are used only to identify products.
Request Glassia
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.